Clinical trial
A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Study Evaluating the Safety and Efficacy of the AThrough Radiofrequency Transseptal Puncture System in Atrial Septal Puncture.
NCT06386458 is registered in ClinicalTrials.gov with Hangzhou NOYA MedTech Co. Ltm. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Study Evaluating the Safety and Efficacy of the AThrough Radiofrequency Transseptal Puncture System in Atrial Septal Puncture.
- Lead sponsor
- Hangzhou NOYA MedTech Co. Ltm.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 8, 2022
- Completion date
- May 11, 2023
- Enrollment
- 177 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.